U.S. Food Stock News

National HealthCare (NHC) has drawn attention after reporting strong revenue growth and expansion across its inpatient and homecare divisions. Investors are watching as the company’s rising free cash flow and steady dividend strategies continue to shape its outlook. See our latest analysis for National HealthCare. National HealthCare’s share price has gained strong momentum in recent months, climbing nearly 31% over the past 90 days and sitting at $123.51 as of the latest close. The company’s...

Amidst a backdrop of U.S.-China trade tensions and ongoing government shutdown, major stock indexes have ended lower as investors digest recent earnings reports. In this challenging market environment, identifying promising small-cap stocks can be pivotal, especially those that show resilience and potential for growth despite broader economic pressures.

As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have recently faced downward pressure. In such a volatile environment, identifying high growth tech stocks requires careful consideration of their resilience to geopolitical issues and their ability to innovate amidst economic challenges.

Major stock indexes in the United States recently ended lower as investors grappled with earnings reports and renewed U.S.-China trade tensions. Despite these challenges, penny stocks remain an intriguing investment option for those seeking growth opportunities in smaller or newer companies. While the term "penny stocks" might seem outdated, these investments can still offer surprising value when backed by strong financials, providing a potential mix of stability and long-term potential.

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

If you have Varonis Systems on your watchlist, you are not alone. Plenty of investors are debating their next move after what has been an eventful run for the stock. Over the past year, shares are up 8.2%, and if you zoom out to a three-year lens, the jump is a staggering 128.8%. That kind of long-term gain stands out, especially considering this year alone has already seen a robust 38.1% rise. Even in the shorter term, Varonis has eked out steady growth, nudging up 1.1% over the last week...

Cinemark Holdings (CNK) shares have pulled back over the past month, sliding around 6%. With the stock down about 15% for the year, some investors are weighing what could drive a turnaround in the future. See our latest analysis for Cinemark Holdings. The recent slide in Cinemark Holdings' share price signals that momentum has cooled, as the stock’s 1-month share price return dipped 6% and its year-to-date loss now sits at 15%. Even so, the bigger picture shows long-term investors have still...

Recent survey data shows that 59% of U.S. homeowners plan to embark on home improvement projects over the next year, with Home Depot remaining the preferred retailer for these renovations. This cautious but growing interest among homeowners signals a potential turning point for the home improvement sector, which could support demand for Home Depot’s products and services. We'll examine how renewed homeowner demand for renovations might update Home Depot's investment narrative and outlook for...

Ternium (NYSE:TX) shares have been making subtle moves this month, catching the eye of investors interested in the materials sector. The stock’s steady gains over the past 3 months suggest ongoing resilience. See our latest analysis for Ternium. After a vibrant run so far this year, Ternium's share price has notched a year-to-date return of 21.5 percent, with short-term momentum continuing to build following a strong 13.3 percent share price return over the last three months. Looking at the...

Aurinia Pharmaceuticals announced that five new scientific posters of real-world and clinical data on LUPKYNIS (voclosporin) were presented in collaboration with independent investigators at the American College of Rheumatology (ACR) Convergence 2025 in Chicago and the American Society of Nephrology (ASN) Kidney Week 2025 in Houston. This spotlight on clinical evidence and expanded real-world usage scenarios may further broaden visibility and clinical understanding of LUPKYNIS among...

If you are holding shares of Crown Castle or considering buying in, you are probably wondering if now is the right time to make a move. After all, Crown Castle has been anything but boring recently. Despite a minor dip of 0.4% in the past week, the stock has climbed 3.6% over the last month and is up a solid 9.5% for the year to date. Yet, the longer view is mixed, as Crown Castle still sits nearly 7% lower than this time last year and down over 21% since five years ago. These numbers raise...

Blackstone Mortgage Trust (BXMT) shares edged up slightly following a period of muted trading, as investors continue to digest the company's recent performance. Over the past month, the stock has slipped by about 4%, which highlights some market caution. See our latest analysis for Blackstone Mortgage Trust. While Blackstone Mortgage Trust’s share price has faced some pressure recently, its year-to-date price return is still in positive territory, and the 1-year total shareholder return sits...

CCC Intelligent Solutions Inc. recently announced that REVV has joined the CCC Diagnostics Network, enabling repair shops to automatically deliver AI-driven calibration documentation from REVV's platform directly into CCC ONE workfiles at no added cost for users. This integration streamlines repair workflow management and documentation for growing vehicle complexity, offering enhanced digital connectivity and seamless access for both repairers and insurers. We'll explore how direct...

If you have been eyeing Safehold lately, you are hardly alone. Whether you already own shares or are considering your options, the recent price swings have probably caught your attention. Safehold closed at $15.84 and has experienced a bumpy ride, with a modest 1.7% uptick this past week, but still lagging over the longer term. The stock has dropped 1.5% in the last month, is down 15.2% since the start of the year, and has lost a notable 29.3% across the past twelve months. Looking back even...

Elevance Health (ELV) delivered revenue growth forecasts of 3.2% annually, trailing the US market’s expected pace of 10% per year. EPS is projected to rise 10.8% each year, again underperforming the 15.5% growth outlook for the broader market. The company’s net profit margin compressed to 2.8%, down from 3.7% a year ago, and recent negative earnings growth makes year-over-year acceleration less meaningful compared to longer-term trends. Shares are trading at $345.21, well below an estimated...

SentinelOne (S) shares slipped about 3% recently, as investors responded to shifting sentiment in the cybersecurity sector. While the company has posted double-digit revenue growth over the past year, its stock has struggled in the past month. See our latest analysis for SentinelOne. Zooming out, SentinelOne’s share price return is down more than 23% year-to-date and it has fallen roughly 10% over the past month, highlighting persistent investor caution despite strong revenue growth. The...

If you’re standing at the crossroads wondering whether to buy, sell, or simply wait when it comes to Beacon Financial stock, you’re not alone. The past few months have been anything but predictable. With the share price closing at $24.22 and marking a dip of 2.8% over the last week, some investors might see warning signs, but others see a window of opportunity. Step back just a little, and a 3.2% slide over the past month paints a similar picture, with the year-to-date return off by 13.3%...

Are you trying to figure out whether Monster Beverage deserves a spot in your portfolio right now? You’re not alone. The stock has been anything but sleepy lately, rising 1.6% in the past week and up a solid 9.0% over the last month. Zoom out and you’ll see even more reason for curiosity, with a 33.3% year-to-date return and a five-year surge of 80.2%. That is serious outperformance, which naturally brings up the big question: has all this good news already been priced in, or could there be...

Earlier this week, TriMas Corporation announced quarterly earnings that surpassed consensus estimates, with revenue increasing by 14.2% year-over-year, and updated its full-year 2025 earnings guidance to an EPS range of 1.950-2.100. This performance follows moves by several institutional investors, including KLP Kapitalforvaltning AS, to adjust their positions in TriMas, highlighting how recent results can influence institutional portfolios. We'll examine how TriMas' stronger quarterly...

The Morning Bull - US Market Morning Update Thursday, Oct, 23 2025 US equity futures are mixed this morning as investors navigate low Treasury yields and shifting interest rate expectations. With the 10-year yield parked near one-year lows and a widely anticipated Federal Reserve rate cut on the horizon, the focus turns to what easier policy might mean for consumer activity and borrowing. The upcoming inflation report is set to influence sentiment, prompting investors to weigh whether lower...

Goldman Sachs recently reported third-quarter net income of US$4.10 billion, up from US$2.99 billion a year earlier, as part of a strong set of earnings results and confirmed a quarterly dividend of US$4.00 per share for December 2025. Heightened investor confidence was further supported by widely shared positive commentary regarding CEO David Solomon’s leadership and a consistent stream of new fixed-income offerings, highlighting active capital markets engagement. We’ll now examine how...

eXp World Holdings (EXPI) has captured the market’s attention with a series of strategic launches, including an AI business assistant, dedicated agent training in automation, and a new division focused on sports and entertainment clients. Investors may be watching to see how these moves improve earnings potential and long-term growth. See our latest analysis for eXp World Holdings. eXp’s share price has been relatively steady in recent months, with a 1.2% gain over the last week and a 3.2%...

Enphase Energy (ENPH) has been moving steadily in recent trading, prompting investors to take a closer look at the stock's valuation and recent performance. The past month has seen a loss of 11%. See our latest analysis for Enphase Energy. Following the recent slide, Enphase Energy’s share price momentum remains subdued. The stock is down nearly 11% over the past month and has registered a year-to-date price return of minus 49%. Looking back over the past year, the total shareholder return is...

Perspective Therapeutics recently presented updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET for advanced neuroendocrine tumors at the ESMO Congress 2025, highlighting a 44% objective response rate in Cohort 2 and a favorable safety profile with no dose limiting toxicities. An important insight is that the therapy maintained disease control for most patients at 41 weeks median follow-up, but investor reactions signaled higher expectations for efficacy...